Matches in Wikidata for { <http://www.wikidata.org/entity/Q97531073> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q97531073 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97531073 description "scientific article published on 14 July 2020" @default.
- Q97531073 description "wetenschappelijk artikel" @default.
- Q97531073 description "наукова стаття, опублікована 14 липня 2020" @default.
- Q97531073 name "Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial" @default.
- Q97531073 name "Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial" @default.
- Q97531073 type Item @default.
- Q97531073 label "Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial" @default.
- Q97531073 label "Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial" @default.
- Q97531073 prefLabel "Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial" @default.
- Q97531073 prefLabel "Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial" @default.
- Q97531073 P1433 Q97531073-BB1339A1-6133-400F-ACB6-03BC639EFEFC @default.
- Q97531073 P1476 Q97531073-F0FE93CE-073E-497A-8E93-E0775774A85A @default.
- Q97531073 P2093 Q97531073-83553914-1C95-4F62-ACB5-694AB3B0DBF1 @default.
- Q97531073 P2093 Q97531073-B28C686E-2F68-4C0A-B196-2A3B016A8BC3 @default.
- Q97531073 P2093 Q97531073-CF341C8D-93ED-403E-A604-064E8EB4F067 @default.
- Q97531073 P2093 Q97531073-DC36C4A8-4488-4DD2-8E5F-B65FB7A7089A @default.
- Q97531073 P31 Q97531073-F54E7EC3-6F8D-43BA-BBA3-776EA41D5D22 @default.
- Q97531073 P356 Q97531073-EE806408-EBF4-4743-88E9-10C50F137DEB @default.
- Q97531073 P50 Q97531073-B4D380E0-119C-4045-918C-40DEB33D170F @default.
- Q97531073 P577 Q97531073-D504EEF3-61D5-4958-A2F5-D580DF6FFE41 @default.
- Q97531073 P698 Q97531073-FD1B9AC0-4FD4-4E0D-A56C-70A3A941D31A @default.
- Q97531073 P921 Q97531073-0FA5221E-470B-411D-B1A6-79E97BD917D1 @default.
- Q97531073 P921 Q97531073-38531FF0-5BA3-454E-AE7A-73CA34320495 @default.
- Q97531073 P356 S11136-020-02580-9 @default.
- Q97531073 P698 32666333 @default.
- Q97531073 P1433 Q15749950 @default.
- Q97531073 P1476 "Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial" @default.
- Q97531073 P2093 "Jan J V Busschbach" @default.
- Q97531073 P2093 "Reinier Timman" @default.
- Q97531073 P2093 "Sankha Amarakoon" @default.
- Q97531073 P2093 "Tom Missotten" @default.
- Q97531073 P31 Q13442814 @default.
- Q97531073 P356 "10.1007/S11136-020-02580-9" @default.
- Q97531073 P50 Q90442630 @default.
- Q97531073 P577 "2020-07-14T00:00:00Z" @default.
- Q97531073 P698 "32666333" @default.
- Q97531073 P921 Q27429789 @default.
- Q97531073 P921 Q413299 @default.